Effective November 1, 2025, Pennant acquired the operations and real property of a 55-bed assisted living community in Lewiston, Idaho. This community, now known as Twin Rivers Senior Living, ...

Mesoblast’s Ryoncil ® (remestemcel-L-rknd) for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months and older is the first FDA-approved ...

Presentation will highlight preclinical data supporting the potential of WVE-007 (INHBE GalNAc-siRNA) as a unique approach for the treatment of obesity designed to drive fat loss while preserving ...

With obesity and metabolic health challenges on the rise, XMD Wellness provides a timely, evidence-based solution. The combination of innovative therapies, telehealth accessibility, and personalized ...

- Conference call scheduled for Wednesday, November 12, 2025, at 4:30 pm ET - ...

To access the live webcasts or subsequent archived recordings of the fireside chats, please visit the RAPT Therapeutics website at https://investors.rapt.com/events-and-presentations.

Protara is among 50 U.S. employers on BioSpace’s Best Places to Work list, with 20 organizations ranked in large and 30 ranked in small employer categories. Protara received the award in the small ...

The Option awards are subject to the award holder’s continuous service through each vesting date and to the terms and conditions of the Plan and its standard forms of grant agreements thereunder.

An audio webcast of the discussions will be available online at the OrthoPediatrics’ investor relations website, http://ir.orthopediatrics.com. Additionally, a replay will be available for 90 days ...

To listen to a live webcast of any of these events, or access archived webcasts, please visit: https://ir.revmed.com/events-and-presentations. Following the live webcasts, replays will be available on ...

En cliquant sur ce lien, vous acceptez l'utilisation de cookies sur ce site internet.

Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the TD Cowen ...